CRMD

CorMedix Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-05

Figures on this page computed 2026-11-08 13:17 UTC

Last close

5.66USD

Market data, 2026-11-04

CRMD: weekly closes from 10.76 on 2025-11-07 to 5.66 on 2026-11-04, a move of -47.4%. Prices in USD.

Weekly closes, 2025-11-07 to 2026-11-04

Over that span: -47.4%

Except where said otherwise: 10-K for 2025, filed 2026-03-05

2.4xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
52.3%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
55.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

7.86x

-19.87x

-22.79x

n/a

0.91x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

4 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-05

Sales7.86x
Its own average over 9 years, 39.7M.
Profit-19.87x
Its own average over 10 years, -8.2M.
Free cash flow-22.79x
Its own average over 10 years, -7.6M.
Debtn/a
Its own average over 9 years, 1.1M.
Price0.91x
Its own average over 11 years, 6. Market data, 2026-11-04

Free cash flow is furthest from its own average, at -22.79 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	n/a
2017-12-31	147.0	n/a
2018-12-31	191.8	n/a
2019-12-31	126.4	n/a
2020-12-31	106.7	n/a
2021-12-31	85.2	100.0
2022-12-31	29.2	106.9
2023-12-31	n/a	135.1
2024-12-31	19,398.1	0.2
2025-12-31	139,090.6	0.2

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001213900-26-023889
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001213900-26-023889
Reported in: USD

The filing itself

Figures behind the shape

Growth

319.8%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate319.8%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income1009.4%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

40.2%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on equity40.2%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
Return on assets19.7%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself

Margins

88.5%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross margin88.5%
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Operating margin48.2%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Net margin52.3%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Free cash flow margin55.4%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself

Price

2.4x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earnings2.4x
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
Price to book1.0x10-Q for 2025, filed 2026-08-13
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001410098-26-000056
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-13
- computed
- 10-K for 2025, filed 2026-03-05
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
- 10-K for 2025, filed 2026-03-05
The filing itself
Price to sales ratio1.3x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself

Safety

2.11

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-Q for 2025, filed 2026-08-13
The filing itself
Current ratio2.1110-Q for 2025, filed 2026-08-13
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001410098-26-000056
Reported in
USD
- 10-Q for 2025, filed 2026-08-13
- 10-Q for 2025, filed 2026-08-13
The filing itself
Interest coverage54.0x
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Altman Z-Score1.55
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001213900-26-023889
Reported in
USD
- 10-K for 2025, filed 2026-03-05
- Computed from the 10-K for 2025, filed 2026-03-05
- 10-K for 2025, filed 2026-03-05
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.